Progressive supranuclear palsy
1 paper
Trial sponsors
Novartis Pharmaceuticals Corporation
Company1 trialPhase 248 people
California Pacific Medical Center Research Institute
1 trialPhase 42,721 people
1 trialPhase 344 people
1 trialPhase 2/3
1 trialPhase 2440 people
1 trialPhase 2330 people
1 trialPhase 228 people
1 trialPhase 220 people
Latest
3 in 12 monthsAAIC 2025 Abstract
Smartphone‐Based Finger‐Tapping as a Predictor of Motor and Cognitive Decline in Neurodegenerative Disorders
Study in peopleBiomarkers